MarginsXMarginsX
Home › Markets › Health Care › FTLF

FitLife Brands Inc. (FTLF)

FTLF trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$6.83
-19.46% on the day
Market cap
$64.1M
Micro cap
Revenue · 2025
$81.5M
+26.4% on 2024
Net income · 2025
$6.3M
7.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1374328/000143774926010680/0001437749-26-010680-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerFTLF on Nasdaq
SectorHealth Care
Industry Medicinal Chemicals and Botanical Products
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001374328
SEC industry codeMedicinal Chemicals & Botanical Products
Incorporated inNV

Financials · 2025

LineValue
Revenue$81.5M
Net income$6.3M
Operating income$10.1M
Net margin7.8%
Operating margin12.4%
Revenue growth+26.4%
Cash$1.6M
Total assets$106.3M
P/E (computed)10.1×
P/S (computed)0.8×

Warning signs

Cash runway
Cash-flow positive
$1.1M cash at June 30, 2026
Share count, 1 year
0.0%
2025-08-11 to 2026-08-12 · +5.6% over 3 years
Going-concern doubt
No
10-Q filed August 13, 2026
Insider net buying, 12 months
$75K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-08-13
Cash and burn$1.1M cash; operating cash flow $2.5M a quarter.Report 2026-06-30
Shares outstanding9,391,072 (2026-08-12); 9,391,072 a year earlier; 4,446,161 three years earlier. 3y figure adjusted for splits (2-for-1 overall).Cover page 2026-08-12
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorWeinberg & Company, P.A., Los Angeles, California, United StatesPCAOB Form AP 2026-04-06
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $75K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$26.5M$1.9M$3.6M$1.1M$6.1M$35.7M10-Q 2026-08-13
Q1 2026
2026-03-31
$25.3M$1.7M$2.5M$1.2M$6.1M$25.3M10-Q 2026-05-14
Q4 2025
2025-12-31
-$39.6M-$2.7M$244K$1.6M$6.1M$15.9M10-Q 2026-05-14
Q3 2025
2025-09-30
$23.5M$921K$3.7M$3.5M$46.5M$70.6M10-Q 2025-11-13
Q2 2025
2025-06-30
$16.1M$1.7M$1.2M$1.5M$6.3M$63.1M10-Q 2026-08-13
Q1 2025
2025-03-31
$15.9M$2.0M$2.3M$5.9M$7.4M$63.9M10-Q 2026-05-14
Q4 2024
2024-12-31
$15.0M$2.1M$957K$4.5M$13.1M$64.5M10-K 2026-03-31
Q3 2024
2024-09-30
$16.0M$2.1M$2.0M$4.7M$9.7M$62.8M10-Q 2025-11-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FORM S-3
S-32024-11-14
Latest annual report
FORM 10-K/A
10-K/A2026-04-21
Latest quarterly / interim
FORM 10-Q
10-Q2026-11-16
Latest current report
FORM 8-K
8-K2026-09-09
Latest proxy
FORM DEFA14A
DEFA14A2026-06-26

Source: SEC EDGAR submissions feed, 540 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+6.3%
1 month-6.5%
3 months-24.2%
Year to date-47.9%
1 year-54.0%
From 52-week high-54.5%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medicinal Chemicals and Botanical Products

TickerCompanyPriceDayMarket cap
ISPRIspire Technology Inc.$1.52-10.06%$87.8M
GLASGlass House Brands Inc. Subordinate Voting Shares$1.29+1.57%$113.5M
BTMDBiote Corp.$0.9603-9.83%$34.5M
NAGENiagen Bioscience Inc.$2.01-2.66%$159.2M
MDWDMediWound Ltd.$13.55+5.04%$195.0M
CGCCanopy Growth Corporation Common Shares$0.5460-2.71%$231.2M
USNAUSANA Health Sciences Inc.$13.54+2.27%$250.3M
ACBAurora Cannabis Inc. Common Shares$4.61-6.68%$303.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier